Alterola Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, net loss was USD 3.21 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0033 USD | -10.81% | -10.81% | -8.33% |
1st Jan change | Capi. | |
---|---|---|
-8.33% | 4.56M | |
+7.95% | 113B | |
+10.39% | 106B | |
+0.41% | 22.27B | |
-12.03% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-4.71% | 17.24B | |
+6.67% | 14.29B | |
+36.17% | 12.52B |